Dicerna™ to Report Fourth Quarter and Full Year 2019 Financial Results on Feb. 27, 2020
Feb 20, 2020
Management will host a conference call at
The call can be accessed by dialing (855) 453-3834 or (484) 756-4306 (international) and referencing conference ID 3259673 prior to the start of the call. After the conference call, a replay will be available for seven days. To access the replay, please dial (855) 859-2056 or (404) 537-3406 and refer to conference ID 3259673.
Dicerna™ and GalXC™ are trademarks of
Amy Trevvett, Dicerna Pharmaceuticals, Inc.
Alex Van Rees, SmithSolve
+1 973-442-1555 ext. 111
Lauren Stival, Stern Investor Relations, Inc.